CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$9.23B
1-Year Return
5.79%
This Quarter Return
+6.94%
1 Year Return
+5.79%
3 Year Return
+24.49%
5 Year Return
+69.08%
10 Year Return
+125.75%
AUM
$8.08B
AUM Growth
-$17.9M
(-0.22%)
Cap. Flow
-$768M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
6.66%
Holding
2,830
New
750
Increased
625
Reduced
628
Closed
593
Top Buys
| 1 |
Synopsys
SNPS
|
+$56.8M |
| 2 |
Micron Technology
MU
|
+$48.4M |
| 3 |
Schlumberger
SLB
|
+$42.9M |
| 4 |
Roku
ROKU
|
+$39.7M |
| 5 |
Starbucks
SBUX
|
+$38.9M |
Top Sells
| 1 |
McDonald's
MCD
|
+$77.4M |
| 2 |
Elevance Health
ELV
|
+$75.8M |
| 3 |
Adobe
ADBE
|
+$65.8M |
| 4 |
Nike
NKE
|
+$57.3M |
| 5 |
Salesforce
CRM
|
+$56.7M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 17% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.38% |
| 5 | Financials | 11.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Telefonica
TEF
$30.3B
| $137K | ﹤0.01% |
+35,146
| New | +$137K |
|
1727
Metallus
MTUS
$697M
| $137K | ﹤0.01% |
5,839
-47,798
| -89% | -$1.12M |
|
1728
Liberty Latin America Class C
LILAK
$1.53B
| $137K | ﹤0.01% |
+18,648
| New | +$137K |
|
1729
Nuvation Bio
NUVB
$1.07B
| $137K | ﹤0.01% |
90,604
+74,855
| +475% | +$113K |
|
1730
Skillz
SKLZ
$109M
| $135K | ﹤0.01% |
+21,679
| New | +$135K |
|
1731
Journey Medical
DERM
$187M
| $135K | ﹤0.01% |
+23,438
| New | +$135K |
|
1732
Banco Macro
BMA
$2.8B
| $132K | ﹤0.01% |
4,597
-40,217
| -90% | -$1.15M |
|
1733
Hippo Holdings
HIPO
$933M
| $131K | ﹤0.01% |
+14,418
| New | +$131K |
|
1734
Monro
MNRO
$519M
| $131K | ﹤0.01% |
4,455
-78,916
| -95% | -$2.32M |
|
|
AVDL
1735
Avadel Pharmaceuticals
AVDL
$1.5B
| $131K | ﹤0.01% |
9,247
-9,338
| -50% | -$132K |
|
1736
Acumen Pharmaceuticals
ABOS
$80M
| $130K | ﹤0.01% |
+33,905
| New | +$130K |
|
|
SACH
1737
Sachem Capital Corp
SACH
$62M
| $130K | ﹤0.01% |
+34,752
| New | +$130K |
|
|
MRAI
1738
DELISTED
Marpai, Inc. Class A Common Stock
MRAI
| $130K | ﹤0.01% |
+74,039
| New | +$130K |
|
1739
Recursion Pharmaceuticals
RXRX
$2.11B
| $129K | ﹤0.01% |
+13,104
| New | +$129K |
|
|
BLUE
1740
DELISTED
bluebird bio
BLUE
| $128K | ﹤0.01% |
+4,654
| New | +$128K |
|
1741
Digital Turbine
APPS
$501M
| $128K | ﹤0.01% |
18,690
+956
| +5% | +$6.56K |
|
1742
Lantronix
LTRX
$174M
| $128K | ﹤0.01% |
+21,837
| New | +$128K |
|
1743
Cerus
CERS
$236M
| $127K | ﹤0.01% |
+58,867
| New | +$127K |
|
|
GATO
1744
DELISTED
Gatos Silver, Inc.
GATO
| $126K | ﹤0.01% |
19,233
-36,156
| -65% | -$236K |
|
|
SVM
1745
Silvercorp Metals
SVM
$1.15B
| $126K | ﹤0.01% |
47,788
+29,770
| +165% | +$78.2K |
|
1746
Dynavax Technologies
DVAX
$1.1B
| $125K | ﹤0.01% |
+8,945
| New | +$125K |
|
1747
Douglas Elliman
DOUG
$241M
| $124K | ﹤0.01% |
42,103
-156,512
| -79% | -$462K |
|
|
NXRT
1748
NexPoint Residential Trust
NXRT
$858M
| $123K | ﹤0.01% |
3,585
-9,836
| -73% | -$339K |
|
1749
Akero Therapeutics
AKRO
$3.48B
| $122K | ﹤0.01% |
5,236
-19,010
| -78% | -$444K |
|
1750
Vera Therapeutics
VERA
$1.52B
| $122K | ﹤0.01% |
+7,933
| New | +$122K |
|